Frank Weber
Fortune : 248 417 $ au 31/05/2026
Fortune : 248 417 $ au 31/05/2026
Dr. Frank T.
Weber, MD, is a CEO, Executive Director & Chief Medical Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV and Zambon Biotech SA. Dr. Weber was previously employed as a Chief Medical & Development Officer by Spexis Ltd., a Senior Vice President-European Medical Division by InterMune International AG, a Medical Director by MedNet GmbH, a Chief Medical Officer by Merck KGaA, and a Chief Medical Officer by Merck Serono SA. He received his doctorate degree from Universität zu Köln.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 168 950 ( 0,57% ) | 248 417 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Directeur Général | 14/08/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK KGAA | Directeur Technique/Scientifique/R&D | - |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Corporate Officer/Principal | - |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Directeur Technique/Scientifique/R&D | - |
MedNet GmbH
MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Corporate Officer/Principal | - |
| SPEXIS AG | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
MedNet GmbH
MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Distribution Services |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national